DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil
Figure 2
(a) Overall survival in a followup of 120 months with an estimated probability of overall survival of 41.7%; (b) disease-free survival in a followup of 120 months with an estimated probability of disease-free survival of 23.4%.
(a)
(b)
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.
